By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Matinas BioPharma 

915 Klosterman Road East

Tarpon Springs  Florida  34689  U.S.A.
Phone: 1-908-443-1860 Fax: n/a


Company News
Matinas BioPharma's Lead Antifungal Product Candidate MAT2203 Granted QIDP And Fast Track Designations By FDA 8/18/2015 8:15:22 AM
Matinas BioPharma Announces Abstract On Pharmacokinetics And Efficacy Of Encochleated Atovaquone In Murine Model Of Pneumocystis Accepted For Oral Presentation At IDWeek 2015 7/27/2015 7:26:52 AM
Matinas BioPharma Appoints Infectious Diseases Expert, David S. Perlin, Ph.D., To Scientific Advisory Board 7/23/2015 8:30:21 AM
Matinas BioPharma Announces Two Abstracts Accepted For Presentation On Preclinical Data Of Lead Anti-Infective Product Candidates MAT2203 And MAT2501 At ICAAC/ICC 2015 7/14/2015 7:46:19 AM
Matinas BioPharma To Present At The 12th Anti-Infectives Partnering And Deal Making Conference 7/7/2015 7:21:48 AM
Matinas BioPharma's MAT9001 Demonstrates Superiority In Reducing Triglycerides, Lipids, Apolipoproteins And PCSK9 Levels In Head-To-Head Study With Vascepa 6/15/2015 9:05:50 AM
Matinas BioPharma To Present At The BIO International Convention On June 18, 2015 6/10/2015 8:02:52 AM
Matinas BioPharma Announces Acceptance Of Late-Breaking Abstract On MAT9001 Comparative Study Results Versus Vascepa For Poster Presentation At The National Lipid Association Scientific Sessions 6/4/2015 7:59:33 AM
Matinas BioPharma's MAT9001 Meets Primary And Secondary Endpoints In First Human Trial Versus Vascepa 6/1/2015 10:41:37 AM
Matinas BioPharma To Present At The LD Micro Invitational On June 2, 2015 5/28/2015 7:53:20 AM